Recursion Pharmaceuticals
Biotechnology company · Salt Lake City, Utah, United States · Nasdaq: RXRX
Recursion Pharmaceuticals is a biotechnology company headquartered in Salt Lake City, Utah, United States. Its earliest recorded incorporation is in 2013. Its shares trade on Nasdaq under the ticker RXRX. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $3.5 million in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $246 million sold in a notice filed in 2020.
Recursion Pharmaceuticals at a glance
What does Recursion Pharmaceuticals do?
US government research funding
5 SBIR/STTR small-business research awards from US health agencies, $3.5 million in total (2015 to 2018). NIH funding came from the National Institute on Aging, National Center for Advancing Translational Sciences.
Private fundraising reported to the SEC
12 Form D notices; the most recent reported $245.9 million sold (2020).
Recursion Pharmaceuticals on the BioBridgeX marketplace
CRO · Target ID & Validation, Assay Development & Screening, Hit-to-Lead
Services
Therapeutic areas
Modalities
Unclaimed listing. Claim this profile
Frequently asked questions about Recursion Pharmaceuticals
Where is Recursion Pharmaceuticals headquartered?
Recursion Pharmaceuticals is headquartered in Salt Lake City, Utah, United States.
What does Recursion Pharmaceuticals do?
Recursion Pharmaceuticals is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Recursion Pharmaceuticals a public company?
Yes. Recursion Pharmaceuticals trades on Nasdaq under the ticker RXRX.
When was Recursion Pharmaceuticals founded?
The earliest incorporation on record for Recursion Pharmaceuticals is in 2013, according to public company registers.
Sources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.